Drug Database
Back to search

Netherlands· NL-224ff98873ff

Competact 15 mg/850 mg, tabletten

A metformin and pioglitazone product containing metforminehydrochloride + pioglitazonhydrochloride, registered in Netherlands by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 13 of our 19 countries.

ATC A10BD05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCompetact 15 mg/850 mg, tablettenATCA10BD05REGISTER NO.NL-224ff98873ffPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about metforminehydrochloride + pioglitazonhydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and pioglitazone is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD05 (metformin and pioglitazone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search metformin and pioglitazone products by name

Metformin and pioglitazone · ATC A10BD05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
METFORMINEHYDROCHLORIDE + PIOGLITAZONHYDROCHLORIDE
Manufacturer
CHEPLAPHARM Arzneimittel GmbH
Country
Netherlands (NL)
ATC code
A10BD05
ATC class
Metformin and pioglitazone
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/06/354

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and pioglitazone.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and pioglitazone against other medicinesHow interaction checks work

Metformin and pioglitazone · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and pioglitazone in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and pioglitazone products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Bulgaria · Пизона Комби
  • Czechia · Novapio Plus
  • Spain · Pioglitazona/Metformina Aristo
  • United Kingdom (Northern Ireland) · Pioglitazone And Metformin Hydrochloride Clydesdale Pharma, Pioglitazone/Metformin Torrent Pharma (Uk)
  • Greece · Pioglitazone/Metformin Genepharm
  • Croatia · Novapio Plus
  • Hungary · Pioglitazone / Metformin Genepharm
  • Iceland · Competact
  • Italy · Pioglitazone E Metformina Docgen, Pioglitazone E Metformina Eg
  • Liechtenstein · Competact
  • Norway · Competact
  • Portugal · Metformina + Pioglitazona Biofarmoz, Metformina + Pioglitazona Farmoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aca69472-3467-4b87-93fb-234f4eb1f031
GET /v1/drugs/aca69472-3467-4b87-93fb-234f4eb1f031?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/competact-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Metformin And Pioglitazone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp72905",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON K 30 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "METFORMINEHYDROCHLORIDE",
    "PIOGLITAZONHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2006/07/28",
  "procedure_number": "EMEA/H/C/000655",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/06/354",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about metformin and pioglitazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console